- Bio2Brain Network
- ESRs
- Objectives
- Participants
- Beneficiaries
- Biberach University of Applied Sciences, Germany
- Centre for Research and Technology Hellas, Greece
- Contipro a.s., Czech Republic
- Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland
- European Laboratory for Non-Linear Spectroscopy, Italy
- Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Germany
- MyBiotech GmbH, Germany
- Queen Mary University of London, UK
- The Chancellor Masters and Scholars of the University of Cambridge, UK
- Partnerorganisations
- Beneficiaries
- Blog
- Contact
- Data Protection Information
- Home
- Imprint
- Newsletter unsubscribe
- Newsletter unsubscribe success
- Research
- Challenges
- Projects
- Project 1 – Particle-based formulations for the intransal transmucosal delivery of Biopharmaceuticals
- Project 10 – Development of new micro-polymers for intranasal drug delivery: study of interfacial behaviour with biological membranes
- Project 11 – Rational design of a panel of antibodies targeting Nogo-A
- Project 12 – Rational design of a panel of antibodies targeting LINGO-1
- Project 13 – Hyaluronan based hydrogels for mucosal drug delivery
- Project 2 – Bio-based hydrogels as drug delivery systems for the intranasal transmucosal delivery of Biopharmaceuticals
- Project 3 – (Bio)polymer-based particulate formulations for the intranasal transmucosal delivery of Biopharmaceuticals
- Project 4 – Analysis of mAb transport and its dependency on Fc-interacting molecules in vitro, ex vivo and in vivo
- Project 5 – Safe-by-Design
- Project 6 – Nose to Brain application of wildtype and engineered antibodies in the pathophysiological context in vivo
- Project 7 – Advanced imaging approaches for dissecting the mechanisms of release and trafficking of Biopharmaceuticals
- Project 8 – A computational approach to optimal design of DDS
- Project 9 – Development of new polymeric nanogels as drug delivery systems
- Publications
- Sitemap
